Redesigning heparin.
Rosenberg
R D
RD
D000925:Anticoagulants / Q000737:chemistry / Q000494:pharmacology / Q000627:therapeutic use*; D019644:Arthroplasty, Replacement, Hip; D017984:Enoxaparin / Q000627:therapeutic use; D006493:Heparin / Q000737:chemistry* / Q000494:pharmacology; D006801:Humans; D009844:Oligosaccharides / Q000737:chemistry / Q000494:pharmacology / Q000627:therapeutic use*; D011183:Postoperative Complications / Q000517:prevention & control*; D013329:Structure-Activity Relationship; D020246:Venous Thrombosis / Q000517:prevention & control*
D000925:Anticoagulants; D017984:Enoxaparin; D009844:Oligosaccharides; C064764:PENTA; D006493:Heparin